Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of linagliptine plus metformin versus metformin alone in prediabetic patients

Trial Profile

Effects of linagliptine plus metformin versus metformin alone in prediabetic patients

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Oct 2018

At a glance

  • Drugs Linagliptin (Primary) ; Metformin
  • Indications Prediabetic-state; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Oct 2018 Results evaluating the effect of linagliptin + metformin plus a lifestyle program on glucose metabolism, insulin secretion and beta cell function presented at the 54th Annual Meeting of the European Association for the Study of Diabetes.
    • 05 Oct 2018 Status changed from recruiting to completed.
    • 05 Oct 2018 Results (n=25) presented at the 54th Annual Meeting of the European Association for the Study of Diabetes
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top